Transforming Growth Factor β-Induced Smad1/5 Phosphorylation in Epithelial Cells Is Mediated by Novel Receptor Complexes and Is Essential for Anchorage-Independent Growth

被引:244
作者
Daly, Amanda C. [1 ]
Randall, Rebecca A. [1 ]
Hill, Caroline S. [1 ]
机构
[1] Canc Res UK London Res Inst, Lab Dev Signalling, London WC2A 3PX, England
关键词
D O I
10.1128/MCB.01192-08
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Transforming growth factor beta (TGF-beta) signals predominantly through a receptor complex comprising ALK5 and T beta RII to activate receptor-regulated Smads (R-Smads) Smad2 and Smad3. In endothelial cells, however, TGF-beta can additionally activate Smad1 and Smad5. Here, we report that TGF-beta also strongly induces phosphorylation of Smad1/5 in many different normal epithelial cells, epithelium-derived tumor cells, and fibroblasts. We demonstrate that T beta RII and ALK5, as well as ALK2 and/or ALK3, are required for TGF-beta-induced Smad1/5 phosphorylation. We show that the simultaneous activation of the R-Smads Smad2/3 and Smad1/5 by TGF-beta results in the formation of mixed R-Smad complexes, containing, for example, phosphorylated Smad1 and Smad2. The prevalence of these mixed R-Smad complexes explains why TGF-beta-induced Smad1/5 phosphorylation does not result in transcriptional activation via bone morphogenetic protein (BMP)responsive elements, which bind activated Smad1/5-Smad4 complexes that are induced by BMP stimulation. Thus, TGF-beta induces two parallel pathways: one signaling via Smad2-Smad4 or Smad3-Smad4 complexes and the other signaling via mixed R-Smad complexes. Finally, we assess the function of the novel arm of TGF-beta signaling and show that TGF-beta-induced Smad1/5 activation is not required for the growth-inhibitory effects of TGF-beta but is specifically required for TGF-beta-induced anchorage-independent growth.
引用
收藏
页码:6889 / 6902
页数:14
相关论文
共 46 条
[1]
THE POZ DOMAIN - A CONSERVED PROTEIN-PROTEIN INTERACTION MOTIF [J].
BARDWELL, VJ ;
TREISMAN, R .
GENES & DEVELOPMENT, 1994, 8 (14) :1664-1677
[2]
Cancer-associated transforming growth factor β type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype [J].
Bharathy, Savita ;
Xie, Wen ;
Yingling, Jonathan M. ;
Reiss, Michael .
CANCER RESEARCH, 2008, 68 (06) :1656-1666
[3]
Byfield SD, 2004, TRENDS CELL BIOL, V14, P107
[4]
A transcriptional partner for MAD proteins in TGF-beta signalling [J].
Chen, X ;
Rubock, MJ ;
Whitman, M .
NATURE, 1996, 383 (6602) :691-696
[5]
Smad1 recognition and activation by the ALK1 group of transforming growth factor-β family receptors [J].
Chen, YG ;
Massagué, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (06) :3672-3677
[6]
Determinants of specificity in TGF-β signal transduction [J].
Chen, YG ;
Hata, A ;
Lo, RS ;
Wotton, D ;
Shi, YG ;
Pavletich, N ;
Massagué, J .
GENES & DEVELOPMENT, 1998, 12 (14) :2144-2152
[7]
Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells [J].
David, Laurent ;
Mallet, Christine ;
Mazerbourg, Sabine ;
Feige, Jean-Jacques ;
Bailly, Sabine .
BLOOD, 2007, 109 (05) :1953-1961
[8]
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures [J].
Debnath, J ;
Muthuswamy, SK ;
Brugge, JS .
METHODS, 2003, 30 (03) :256-268
[9]
Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene [J].
Dennler, S ;
Itoh, S ;
Vivien, D ;
ten Dijke, P ;
Huet, S ;
Gauthier, JM .
EMBO JOURNAL, 1998, 17 (11) :3091-3100
[10]
DETERMINATION OF TYPE-I RECEPTOR SPECIFICITY BY THE TYPE-II RECEPTORS FOR TGF-BETA OR ACTIVIN [J].
EBNER, R ;
CHEN, RH ;
LAWLER, S ;
ZIONCHECK, T ;
DERYNCK, R .
SCIENCE, 1993, 262 (5135) :900-902